Logo image of MACU

MALLARD ACQUISITION CORP (MACU) Stock Fundamental Analysis

NASDAQ:MACU - Nasdaq - US5612041088 - Common Stock

10.09  -0.01 (-0.05%)

After market: 10.13 +0.04 (+0.4%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MACU. MACU was compared to 0 industry peers in the Unkown industry. The financial health of MACU is average, but there are quite some concerns on its profitability. MACU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MACU was profitable.
MACU Yearly Net Income VS EBIT VS OCF VS FCFMACU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 0 500K 1M

1.2 Ratios

Industry RankSector Rank
ROA 8.39%
ROE 9.31%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MACU Yearly ROA, ROE, ROICMACU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 0 0.5 1

1.3 Margins

MACU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MACU Yearly Profit, Operating, Gross MarginsMACU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020

More info and screens

5

2. Health

2.1 Basic Checks

MACU has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MACU Yearly Shares OutstandingMACU Yearly Shares OutstandingYearly Shares Outstanding 2020 2M 4M 6M 8M 10M
MACU Yearly Total Debt VS Total AssetsMACU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 20M 40M 60M 80M 100M

2.2 Solvency

MACU has an Altman-Z score of 7.59. This indicates that MACU is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for MACU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.59
ROIC/WACCN/A
WACCN/A
MACU Yearly LT Debt VS Equity VS FCFMACU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 20M 40M 60M 80M

2.3 Liquidity

MACU has a Current Ratio of 0.67. This is a bad value and indicates that MACU is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.67 indicates that MACU may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.67
MACU Yearly Current Assets VS Current LiabilitesMACU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%188127%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.52 indicates a correct valuation of MACU.
Compared to an average S&P500 Price/Earnings ratio of 26.25, MACU is valued a bit cheaper.
Industry RankSector Rank
PE 15.52
Fwd PE N/A
MACU Price Earnings VS Forward Price EarningsMACU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MACU Per share dataMACU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MACU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MALLARD ACQUISITION CORP

NASDAQ:MACU (4/29/2022, 8:23:43 PM)

After market: 10.13 +0.04 (+0.4%)

10.09

-0.01 (-0.05%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.2%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap138.74M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.52
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.38
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.65
EY6.44%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS7.31
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.39%
ROE 9.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.67
Altman-Z 7.59
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%188127%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A